These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 24204125

  • 1. Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer.
    Hua CH, Guo HM, Guan XL, Kong FJ, Hou RJ, Zhang XY, Li SR.
    Patient Prefer Adherence; 2013; 7():1061-6. PubMed ID: 24204125
    [Abstract] [Full Text] [Related]

  • 2. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT, Gebretekle GB, Gebremariam GT, Fenta TG.
    Health Qual Life Outcomes; 2019 Jan 14; 17(1):13. PubMed ID: 30642359
    [Abstract] [Full Text] [Related]

  • 3. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic V, Wydra D, European Organization for Research and Treatment of Cancer Quality-of-Life Group.
    Cancer; 2006 Oct 15; 107(8):1812-22. PubMed ID: 16977652
    [Abstract] [Full Text] [Related]

  • 4. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW, Ahn E, Kim YM, Kang S, Kim BG, Seong SJ, Cha SD, Park CY, Yun YH.
    Oncology; 2009 Oct 15; 76(3):190-8. PubMed ID: 19209009
    [Abstract] [Full Text] [Related]

  • 5. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H, Rajapaksa LC, Greimel ER.
    Psychooncology; 2008 Oct 15; 17(10):1053-7. PubMed ID: 18203241
    [Abstract] [Full Text] [Related]

  • 6. Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer.
    Paradowska D, Tomaszewski KA, Bałajewicz-Nowak M, Bereza K, Tomaszewska IM, Paradowski J, Pityński K, Skotnicki P, Greimel ER, Bottomley A.
    Eur J Cancer Care (Engl); 2014 Mar 15; 23(2):214-20. PubMed ID: 23957381
    [Abstract] [Full Text] [Related]

  • 7. Patients' acceptance and psychometric properties of the EORTC QLQ-CX24 after surgery.
    Singer S, Kuhnt S, Momenghalibaf A, Stuhr C, Dimmel-Hennersdorf U, Köhler U, Einenkel J.
    Gynecol Oncol; 2010 Jan 15; 116(1):82-7. PubMed ID: 19836828
    [Abstract] [Full Text] [Related]

  • 8. An analysis of the psychometric properties of the translated versions of the European Organisation for the Research and Treatment of Cancer QLQ CX24 questionnaire in the two South African indigenous languages of Xhosa and Afrikaans.
    du Toit GC, Kidd M.
    Eur J Cancer Care (Engl); 2016 Sep 15; 25(5):832-8. PubMed ID: 26052872
    [Abstract] [Full Text] [Related]

  • 9. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
    Zhang Z, Zhang X, Wei L, Lin Y, Wu D, Xie S, Yue L, Tian J, Zhang Y, Song Q, Woo SM, Miller AR, Luo L, Zhang L.
    Breast; 2017 Apr 15; 32():87-92. PubMed ID: 28068605
    [Abstract] [Full Text] [Related]

  • 10. The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.
    Cheng JX, Liu BL, Zhang X, Zhang YQ, Lin W, Wang R, Zhang YQ, Zhang HY, Xie L, Huo JL.
    BMC Med Res Methodol; 2011 Apr 22; 11():56. PubMed ID: 21513533
    [Abstract] [Full Text] [Related]

  • 11. Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer.
    Luvián-Morales J, Flores-Cisneros L, Jiménez-Lima R, Alarcón-Barrios S, Salazar-Mendoza J, Castro-Eguiluz D, Cetina-Pérez L, Oñate-Ocaña LF.
    Int J Gynecol Cancer; 2021 Sep 22; 31(9):1228-1235. PubMed ID: 34353855
    [Abstract] [Full Text] [Related]

  • 12. Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer.
    Dai Z, Lang W, Yang H, Tian J, Sun W, Pekbay B, Lin Y, Wang M, Cui B, Yang S, Li H, Luo L, Guo H, Zhang L.
    Dis Esophagus; 2017 Oct 01; 30(10):1-7. PubMed ID: 28859386
    [Abstract] [Full Text] [Related]

  • 13. Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer.
    Zhang J, Xie S, Liu J, Sun W, Guo H, Hu Y, Gao X.
    Patient Prefer Adherence; 2014 Oct 01; 8():1285-92. PubMed ID: 25258522
    [Abstract] [Full Text] [Related]

  • 14. Reliability, validity and responsiveness of the Mandarin (Simplified) Chinese version of the EORTC QLQ-OH45 among cancer patients.
    Liu J, Gao J, Wu CX, Bai DX, Li X, Guo XX, Yu JY, Xiao QQ, Bao XR, He LC, Zhong YZ, Chen S.
    Eur J Cancer Care (Engl); 2019 Mar 01; 28(2):e12987. PubMed ID: 30614580
    [Abstract] [Full Text] [Related]

  • 15. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
    Zhang L, Su YJ, Chen JY, Liao ZC, Luo ZQ, Xie SM, Zhang J, Lin YS, Guo H, Sun WL, Pekbay B, Miller AR, Luo L, Rui YH, Li MH, Wang CL.
    Support Care Cancer; 2016 Mar 01; 24(3):1019-24. PubMed ID: 26245496
    [Abstract] [Full Text] [Related]

  • 16. Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study.
    Davda J, Kibet H, Achieng E, Atundo L, Komen T.
    J Patient Rep Outcomes; 2021 Jan 07; 5(1):4. PubMed ID: 33415528
    [Abstract] [Full Text] [Related]

  • 17. Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Lin JB, Zhang L, Wu DW, Xi ZH, Wang XJ, Lin YS, Fujiwara W, Tian JR, Wang M, Peng P, Guo A, Yang Z, Luo L, Jiang LY, Li QQ, Zhang XY, Zhang YF, Xu HW, Yang B, Li XL, Lei YX.
    World J Gastroenterol; 2017 Mar 14; 23(10):1891-1898. PubMed ID: 28348496
    [Abstract] [Full Text] [Related]

  • 18. Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQ-C30 in Colorectal Cancer Patients.
    Magaji BA, Moy FM, Roslani AC, Law CW, Sagap I.
    Asian Pac J Cancer Prev; 2015 Mar 14; 16(18):8107-12. PubMed ID: 26745046
    [Abstract] [Full Text] [Related]

  • 19. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M, Shamieh O, Hjermstad MJ, Hornslien K, Young T, Chalk T, Ioannidis G, Harle A, Johnson CD, Tomaszewski KA, Serpentini S, Pinto M, van der Weijst L, Janssens A, Morag O, Chie WC, Arraras JI, Pompili C, Jungraithmayr W, Hechtner M, Katsochi D, Müller K, Gräfenstein L, Schulz C, Bottomley A, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, EORTC Lung Cancer Group, European Society of Thoracic Surgeons.
    Lancet Oncol; 2020 May 14; 21(5):723-732. PubMed ID: 32213338
    [Abstract] [Full Text] [Related]

  • 20. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S, Jayasekara P, Abeysinghe P, Hjermstad M, Lalloo R.
    BMC Oral Health; 2022 Aug 19; 22(1):359. PubMed ID: 35986341
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.